UPSIDE Foods, a Berkeley, California-based company that grows meat, poultry and seafood directly from animal cells, becomes the first in the world to receive approval from the U.S. Food and Drug Administration for its lab-grown meat. The FDA said that its meat product is safe for human consumption.
According to Reuters, this is the first time that the U.S. FDA has granted such approval for cultivated meat. The US agency revealed its decision on Wednesday this week. UPSIDE Foods made chicken meat by collecting cells from live animals and using them to cultivate meat inside stainless steel tanks.
With the FDA’s approval, the company may continue with its plans to sell its products. However, in a joint statement, Robert M. Califf, M.D., the commissioner of Food and Drugs - Food and Drug Administration and Susan T. Mayne, Ph.D., the director of Center for Food Safety and Applied Nutrition (CFSAN), said that before UPSIDE Foods can fully proceed with marketing the cell-cultured meat, an inspection from the U.S. Department of Agriculture (USDA) and USDA-Food Safety and Inspection Service (FSIS) are still needed.
At any rate, the American food and drug regulator further said that it had already analyzed data from UPSIDE Foods, and it has no further questions about its conclusion that the lab-grown meat is safe to eat. But then again, the FDA explained that its review is not technically an approval and pointed out that it is only for UPSIDE products and does not apply to other companies in the same business.
"This is a watershed moment in the history of food and we started UPSIDE amid a world full of skeptics, and today, we've made history again as the first company to receive a 'No Questions' letter from the FDA for cultivated meat,” UPSIDE Foods’ founder and chief executive officer, Dr. Uma Valeti, said in a press release.
The CEO added, “This milestone marks a major step towards a new era in meat production, and I'm thrilled that U.S. consumers will soon have the chance to eat delicious meat that's grown directly from animal cells."


Baige Online Shares Soar 333% in Hong Kong IPO Debut as AI Insurance Demand Lifts Chinese Listings
SpaceX, Charter Communications Explore Mobile Partnership to Expand Starlink Wireless Service
US Judge Seeks Explanation for DOJ’s Decision to Drop Gautam Adani Bribery Case
US Stock Futures Rise as US-Iran Ceasefire Hopes Boost Market Sentiment
Kakaku.com Shares Rise as Bain Capital and LY Corp Prepare Higher Takeover Bid Than EQT
Trip.com Shares Tumble After Q1 Profit Drops and Weak Revenue Growth Outlook
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign
Asian Currencies Stay Range-Bound as Investors Eye China Data, RBNZ Outlook and U.S.-Iran Ceasefire
SK Hynix Targets $29.4 Billion Nasdaq Listing to Expand AI Chip Business
China Sets 1.25% Overnight Reverse Repo Rate Below Market Expectations
Amazon Prime Day 2026 Sales Top $26.4 Billion as Shoppers Chase Discounts Amid Inflation
Asian Currencies Trade Mixed as Yen Hovers Near 40-Year Low, Dollar Holds Firm on Fed Outlook
Oil Prices Drop as Middle East Supply Recovery Eases Market Concerns
Samsung, SK Hynix to Unveil $1.3 Trillion AI and Semiconductor Investment Plan
Japan Targets 1%+ Real Economic Growth With ¥370 Trillion Investment Plan
Bayer Wins Major U.S. Supreme Court Roundup Lawsuit, Shares Surge
Trump Threatens 100% Tariffs on Countries Imposing Digital Services Taxes on U.S. Tech Firms 



